Pfizer Inc. has announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In this role, Dr.

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Legos holds a PhD in physiology from Temple University and an MBA in finance from Villanova University. He has also written ...

US pharma giant Pfizer (NYSE: PFE) today announced that Jeffrey Legos will join the company as chief oncology officer.

After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Trump's FDA pick is surgeon and writer Martin Makary November 23, 2024 Pfizer said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and ...

Aamir Malik; Executive Vice President, Chief US Commercial Officer; Pfizer Inc Andrew Baum; Chief Strategy and Innovation Officer, Executive Vice President; Pfizer Inc Alexandre De Germay; Executive ...

2025 Expected Net Savings from Cost Realignment: $4.5 billion by the end of 2025. Pfizer Inc (NYSE:PFE) successfully integrated the Seagen business, enhancing its oncology capabilities. The company ...